(R)-Carisbamate

CAS No. 194085-74-0

(R)-Carisbamate( —— )

Catalog No. M23882 CAS No. 194085-74-0

(R)-Carisbamate is the R-isomer of Carisbamate . Carisbamate is an experimental anticonvulsant drug.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 69 In Stock
2MG 50 In Stock
5MG 77 In Stock
10MG 110 In Stock
25MG 199 In Stock
50MG 277 In Stock
100MG 397 In Stock
200MG 550 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (R)-Carisbamate
  • Note
    Research use only, not for human use.
  • Brief Description
    (R)-Carisbamate is the R-isomer of Carisbamate . Carisbamate is an experimental anticonvulsant drug.
  • Description
    (R)-Carisbamate is the R-isomer of Carisbamate . Carisbamate is an experimental anticonvulsant drug.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    194085-74-0
  • Formula Weight
    215.63
  • Molecular Formula
    C9H10ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O[C@H](C1=CC=CC=C1Cl)COC(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • H-Tyr-Ile-Gly-Ser-Ar...

    YIGSR is a peptide that can inhibit the tumour growth and metastasis of leukaemic cells. YIGSR blocks the cellular binding to laminin I via a 67-kDa laminin-binding protein, and inhibits shear-induced increase in eNOS expression of laminin cells.

  • 4-O-METHYLDAVIDIGENI...

    4-O-METHYLDAVIDIGENIN

  • CHR-6494 TFA

    CHR-6494 TFA is a potent haspin inhibitor, with an?IC50?of 2 nM. It inhibits histone H3T3 phosphorylation. CHR-6494 TFA induces the?apoptosis?of cancer cells, including melanoma and breast cancer. CHR-6494 TFA can be used in the research of cancer.